Home News room Press releases

November 4

GlaxoSmithKline Pharmaceuticals announces financial results for Third Quarter of FY 2011

August 10

GlaxoSmithKline Pharmaceuticals Net Sales up 13% in Second Quarter of FY 2011

July 22

GlaxoSmithKline Pharmaceuticals Limited announces launch of two drugs

May 6

GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%, Profit After Tax (before exceptionals) grows by 16% in First Quarter of FY 2011

February 14

GlaxoSmithKline Pharmaceuticals Net Sales up by 12.9%, PAT before Exceptional Items grows by 15.1% in FY 2010

October 28

GlaxoSmithKline Pharmaceuticals Net Sales up 14%, PBT before Exceptional Items grows by 14%

July 26

GlaxoSmithKline Pharmaceuticals Net Sales up 9%, Operating Profit before Investment Income grows by 14% in Second Quarter of FY 2010

April 27

GlaxoSmithKline Pharmaceuticals Net Sales up 18% PAT , before Exceptional Items grows by 28% in First Quarter of FY 2010

March 8

GSK’s CEO, Andrew Witty dedicates Albendazole facility in Nashik to WHO's global programme to eliminate Lymphatic Filariasis (LF)

February 26

GlaxoSmithKline Pharmaceuticals Limited response to recent media reports on Rosiglitazone

February 15

GlaxoSmithKline Pharmaceuticals Net Sales up 21%, PAT before Exceptional Items grows by 20% in Fourth Quarter of FY 2009

October 30

GlaxoSmithKline Pharmaceuticals Net Sales up 12% in Third Quarter of FY 2009

July 27

GlaxoSmithKline Pharmaceuticals Net Sales up 10%, PBT grows by 17% in Second Quarter of FY 2009

July 17

Three Clinical studies give GlaxoSmithKline’s Cervical Cancer vaccine- Cervarix™ a clear edge

April 18

GlaxoSmithKline Pharmaceuticals Net Sales up 9.3%, PBT grows by 7.9% in First Quarter of FY 2009

February 18

GlaxoSmithKline Pharmaceuticals Net Sales up 10%, PBT grows by 15% for FY 2008

October 24

GlaxoSmithKline Pharmaceuticals Profits up by 21%, Net Sales up 15% in third Quarter of FY 2008

July 28

GlaxoSmithKline Pharmaceuticals Profits up by 19%, Net Sales up 11% in Second Quarter of FY 2008

April 21

GlaxoSmithKline Pharmaceuticals Profits up by 12% in First Quarter of FY 2008

February 22

GlaxoSmithKline Pharmaceuticals Sales up by 14%, PBT grows by 25% for Fourth Quarter

January 30

GlaxoSmithKline launches two new innovative vaccines

July 26

GSK Divests its Fine Chemicals Business

February 16

GlaxoSmithKline Pharmaceuticals Net Profit up 16.3%

September 18

GSK announces DREAM results in India

May 10

GlaxoSmithKline introduces the Heppos

May 2

GlaxoSmithKline launches Asthma Control Test

April 28

Virbac Acquires GSK's Animal Health Business

February 13

GlaxoSmithKline Pharmaceuticals' Net Profit up 15.1%

February 8

59% of schoolchildren may be at risk of contracting chickenpox

January 25

GSK launches the Suraksha Kawach programme

Archives

August 30

GSK at Vivaaha Mumbai

August 10

GSK launches the low dose pill Bangalore

August 5

GSK at Vivaaha Delhi

June 16

GSK launches the LDP Hyderabad

May 26

Eisai India and GSK signed an agreement

May 12

GSK India's Clinical Data Management & Analyses Centre B'lore

March 15

GSK India Announces Buyback

February 22

GSK to Manufacture Vaccines in Nashik, India

Investors

This section of our website contains essential information on GSK's financial performance.

• Investors

This section may contains information in several formats:

To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.

For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.